CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE5631.406.2 (+0.11 %)
PREV CLOSE () 5625.20
OPEN PRICE () 5632.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 462
TODAY'S LOW / HIGH ()5585.25 5649.75
52 WK LOW / HIGH ()4498.9 5867.5
NSE5631.005 (+0.09 %)
PREV CLOSE() 5626.00
OPEN PRICE () 5666.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 5631.00 (82)
VOLUME 35892
TODAY'S LOW / HIGH() 5587.50 5676.00
52 WK LOW / HIGH ()4491.65 5868
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1973

Management Info :

Basudeo N Singh - Chairman Sandeep Singh - Managing Director

Registered Office :

Address : Alkem House,Senapati Bapat Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone : 022 3982 9999

Website : www.alkemlabs.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
12Dec Alkem Laboratories informs about news
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
10Dec Malta Medicines Authority concludes GM
Malta Medicines Authority has concluded GMP inspection at Alkem Laborato..
08Dec Alkem Laboratories informs about chang
Alkem Laboratories has informed that Rakesh Tripathi shall cease to hold..
05Dec Alkem Laboratories informs about discl
Pursuant to Regulation 30 read with Schedule III of SEBI LODR Regulation..
25Nov Alkem Laboratories informs about inve
With reference to relevant provisions of the SEBI (Listing Obligations a..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit7867.322808.9
Gross Profit 8007.1 23035.4
Operating Profit 8720.526632.6
Net Sales 25420.388134.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1128.80 (6.39%)
M.Cap ( in Cr)
777.96
Amrutanjan Healthcar (BSE)
 689.65 (6.38%)
M.Cap ( in Cr)
1993.82
Lupin (BSE)
 2114.10 (1.62%)
M.Cap ( in Cr)
96571.84
Panacea Biotec (BSE)
 362.70 (9.53%)
M.Cap ( in Cr)
2221.56
Emcure Pharma (BSE)
 1439.60 (2.18%)
M.Cap ( in Cr)
27289.76
Shareholding Pattern
PROMOTERS 51.2%
NON-INSTITUTION 17.4%
MUTUAL FUNDS/UTI 16.94%
FI/BANKS/INSURANCE 3.62%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX85267.66449.53 (0.53%)
NIFTY26046.95148.40 (0.57%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI